X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

CCCC

Closed

C4 Therapeutics inc

1.51
+0.08 (+5.59%)
Last Update: 01 Jul 2025 23:08:00
Yesterday: 1.43
Day's Range: 1.395 - 1.5991
Send
When Written:
 
3.14
C4 Therapeutics Inc is a biotechnology company that focuses on developing small molecule drugs that target disease-causing proteins for degradation. The company's platform technology, called Degronimid, enables the design of small molecules that can selectively bind to specific proteins and trigger their degradation by the cell's natural protein disposal machinery. This approach has the potential to treat a wide range of diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. C4 Therapeutics was founded in 2015 and is headquartered in Watertown, Massachusetts. The company has partnerships with several pharmaceutical companies, including Roche, Biogen, and Calico.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X